Markers important in obesity and efferocytosis (e.g., PS, ADAM17, TNF-α, and sMER) were observed between the obese and nonobese groups, opening the opportunity to identify potential biomarkers for therapeutic exploration. The gene discussed is ADAM17; the disease is obesity disorder.